Skip to main content

Advertisement

SpringerLink
Log in

BRCA1 and BRCA2: Chemosensitivity, Treatment Outcomes and Prognosis

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

BRCA1 and BRCA2 are important breast and ovarian cancer susceptibility genes, and mutations in these two genes confer lifetime risks of breast cancer of up to 80% and ovarian cancer risks of up to 40%. Clinico-pathological studies have identified features that are specific to BRCA1-related breast cancer, but this has been more difficult for BRCA2-related breast cancer. Ovarian cancers due to BRCA1 or BRCA2 mutations cannot usually be distinguished from their non-hereditary counterparts on morphological grounds, but micro-array data suggest that differences do exist. Prognostic studies have shown that breast cancer in a BRCA1 mutation carrier is likely to have a similar, or worse, outcome than that occurring in a BRCA2- or non-carrier of the same age. By contrast, most studies indicate that women developing a BRCA1/2-related ovarian cancer have an improved survival compared with non-carriers, particularly if they receive platinum-based therapy. In support of this, in vitro chemo-sensitivity studies have found that human cells lacking BRCA1 may be particularly sensitive to cisplatinum and to other drugs that cause double-strand breaks in DNA. Nevertheless, in breast cancer, little is known regarding clinically important differences in response to chemotherapy between BRCA1/2 mutation carriers and non-carriers, and between different chemotherapeutic regimens within existing series of BRCA1/2 mutation carriers. There are no published prospective studies. It is hoped that, in the near future, randomised controlled trials will be started with the aim of answering these important clinical questions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. SA Narod WD Foulkes (2004) ArticleTitleBRCA1 and BRCA2: 1994 and beyond Nat Rev Cancer 4 IssueID9 665–76 Occurrence Handle15343273 Occurrence Handle1:CAS:528:DC%2BD2cXntFCmsbk%3D Occurrence Handle10.1038/nrc1431

    Article  PubMed  CAS  Google Scholar 

  2. A Andermann SA Narod (2002) ArticleTitleGenetic counselling for familial breast and ovarian cancer in Ontario J Med Genet 39 IssueID9 695–6 Occurrence Handle12205116 Occurrence Handle1:STN:280:DC%2BD38vkvVWqtA%3D%3D Occurrence Handle10.1136/jmg.39.9.695

    Article  PubMed  CAS  Google Scholar 

  3. DG Evans A Howell (2004) ArticleTitleAre BRCA1- and BRCA2-related breast cancers associated with increased mortality? Breast Cancer Res 6 IssueID1 E7 Occurrence Handle14680492 Occurrence Handle10.1186/bcr748

    Article  PubMed  Google Scholar 

  4. T Sorlie CM Perou R Tibshirani et al. (2001) ArticleTitleGene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 IssueID19 10869–74 Occurrence Handle11553815 Occurrence Handle1:CAS:528:DC%2BD3MXntVGmsbo%3D Occurrence Handle10.1073/pnas.191367098

    Article  PubMed  CAS  Google Scholar 

  5. LJ Veer ParticleVan’t HY Dai MJ Vijver Particlevan de et al. (2002) ArticleTitleGene expression profiling predicts clinical outcome of breast cancer Nature 415 IssueID6871 530–6 Occurrence Handle10.1038/415530a

    Article  Google Scholar 

  6. C Sotiriou SY Neo LM McShane et al. (2003) ArticleTitleBreast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 IssueID18 10393–8 Occurrence Handle12917485 Occurrence Handle1:CAS:528:DC%2BD3sXntFynsrk%3D Occurrence Handle10.1073/pnas.1732912100

    Article  PubMed  CAS  Google Scholar 

  7. I Hedenfalk D Duggan Y Chen et al. (2001) ArticleTitleGene-expression profiles in hereditary breast cancer N Engl J Med 344 IssueID8 539–48 Occurrence Handle11207349 Occurrence Handle1:CAS:528:DC%2BD3MXhsFGks7o%3D Occurrence Handle10.1056/NEJM200102223440801

    Article  PubMed  CAS  Google Scholar 

  8. C Sotiriou C Khanna AA Jazaeri et al. (2002) ArticleTitleCore biopsies can be used to distinguish differences in expression profiling by cDNA microarrays J Mol Diagn 4 IssueID1 30–6 Occurrence Handle11826185 Occurrence Handle1:CAS:528:DC%2BD38XitVGju7s%3D

    PubMed  CAS  Google Scholar 

  9. SR Lakhani MJ Vijver Particlevan de J Jacquemier et al. (2002) ArticleTitleThe pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 IssueID9 2310–8 Occurrence Handle11981002 Occurrence Handle1:CAS:528:DC%2BD38XktVKrs7o%3D Occurrence Handle10.1200/JCO.2002.09.023

    Article  PubMed  CAS  Google Scholar 

  10. WD Foulkes K Metcalfe W Hanna et al. (2003) ArticleTitleDisruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma Cancer 98 IssueID8 1569–77 Occurrence Handle14534871 Occurrence Handle10.1002/cncr.11688

    Article  PubMed  Google Scholar 

  11. PO Chappuis V Nethercot WD Foulkes (2000) ArticleTitleClinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer Semin Surg Oncol 18 287–95 Occurrence Handle10805950 Occurrence Handle1:STN:280:DC%2BD3c3ms1CksQ%3D%3D Occurrence Handle10.1002/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.0.CO;2-5

    Article  PubMed  CAS  Google Scholar 

  12. PO Chappuis L Kapusta LR Begin et al. (2000) ArticleTitleGermline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer J Clin Oncol 18 IssueID24 4045–52 Occurrence Handle11118465 Occurrence Handle1:CAS:528:DC%2BD3MXktFegtQ%3D%3D

    PubMed  CAS  Google Scholar 

  13. MS Greenblatt PO Chappuis JP Bond et al. (2001) ArticleTitleTP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution Cancer Res 61 IssueID10 4092–7 Occurrence Handle11358831 Occurrence Handle1:CAS:528:DC%2BD3MXktVWqtrk%3D

    PubMed  CAS  Google Scholar 

  14. WD Foulkes JS Brunet IM Stefansson et al. (2004) ArticleTitleThe prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer Cancer Res 64 IssueID3 830–5 Occurrence Handle14871808 Occurrence Handle1:CAS:528:DC%2BD2cXhtFCgtLo%3D Occurrence Handle10.1158/0008-5472.CAN-03-2970

    Article  PubMed  CAS  Google Scholar 

  15. T Sorlie R Tibshirani J Parker et al. (2003) ArticleTitleRepeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 IssueID14 8418–23 Occurrence Handle12829800 Occurrence Handle1:CAS:528:DC%2BD3sXlsFGntLk%3D Occurrence Handle10.1073/pnas.0932692100

    Article  PubMed  CAS  Google Scholar 

  16. WD Foulkes IM Stefansson PO Chappuis et al. (2003) ArticleTitleGermline BRCA1 mutations and a basal epithelial phenotype in breast cancer J Natl Cancer Inst 95 1482–5 Occurrence Handle14519755 Occurrence Handle1:CAS:528:DC%2BD3sXnvVCjtrk%3D

    PubMed  CAS  Google Scholar 

  17. JR Goffin O Straume PO Chappuis et al. (2003) ArticleTitleGlomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer Br J Cancer 89 IssueID6 1031–4 Occurrence Handle12966421 Occurrence Handle1:CAS:528:DC%2BD3sXntVKgu74%3D Occurrence Handle10.1038/sj.bjc.6601195

    Article  PubMed  CAS  Google Scholar 

  18. TA Grushko JJ Dignam S Das et al. (2004) ArticleTitleMYC is amplified in BRCA1-associated breast cancers Clin Cancer Res 10 IssueID2 499–507 Occurrence Handle14760071 Occurrence Handle1:CAS:528:DC%2BD2cXovVGrtg%3D%3D Occurrence Handle10.1158/1078-0432.CCR-0976-03

    Article  PubMed  CAS  Google Scholar 

  19. C Adem CL Soderberg K Hafner et al. (2004) ArticleTitleERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers Genes Chromosomes Cancer 41 IssueID1 1–11 Occurrence Handle15236312 Occurrence Handle1:CAS:528:DC%2BD2cXntVelurg%3D Occurrence Handle10.1002/gcc.20057

    Article  PubMed  CAS  Google Scholar 

  20. E Korsching J Packeisen K Agelopoulos et al. (2002) ArticleTitleCytogenetic alterations and cytokeratin expression patterns in breast cancer: Integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis Lab Invest 82 IssueID11 1525–33 Occurrence Handle12429812 Occurrence Handle1:CAS:528:DC%2BD38XosVCnt70%3D

    PubMed  CAS  Google Scholar 

  21. S Signoretti L Marcotullio ParticleDi A Richardson et al. (2002) ArticleTitleOncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer J Clin Invest 110 IssueID5 633–41 Occurrence Handle12208864 Occurrence Handle1:CAS:528:DC%2BD38Xmslyitrs%3D Occurrence Handle10.1172/JCI200215795

    Article  PubMed  CAS  Google Scholar 

  22. K Malzahn M Mitze M Thoenes R Moll (1998) ArticleTitleBiological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas Virchows Arch Int J Pathol 433 IssueID2 119–29 Occurrence Handle1:CAS:528:DyaK1cXkslyrtLY%3D Occurrence Handle10.1007/s004280050226

    Article  CAS  Google Scholar 

  23. SH Dairkee BH Mayall HS Smith AJ Hackett (1987) ArticleTitleMonoclonal marker that predicts early recurrence of breast-cancer Lancet 1 IssueID8531 514 Occurrence Handle2881076 Occurrence Handle1:STN:280:BiiC2czjtlA%3D

    PubMed  CAS  Google Scholar 

  24. M Rijn Particlevan de CM Perou R Tibshirani et al. (2002) ArticleTitleExpression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome Am J Pathol 161 IssueID6 1991–6 Occurrence Handle12466114

    PubMed  Google Scholar 

  25. SR Lakhani J Jacquemier JP Sloane et al. (1998) ArticleTitleMultifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations J Natl Cancer Inst 90 IssueID15 1138–45 Occurrence Handle9701363 Occurrence Handle1:CAS:528:DyaK1cXlsVOrs78%3D Occurrence Handle10.1093/jnci/90.15.1138

    Article  PubMed  CAS  Google Scholar 

  26. SA Vaziri RR Tubbs G Darlington G Casey (2001) ArticleTitleAbsence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers Mol Pathol 54 IssueID4 259–63 Occurrence Handle11477142 Occurrence Handle1:CAS:528:DC%2BD38XnvFSjtL8%3D Occurrence Handle10.1136/mp.54.4.259

    Article  PubMed  CAS  Google Scholar 

  27. R Desper J Khan AA Schaffer (2004) ArticleTitleTumor classification using phylogenetic methods on expression data J Theor Biol 228 IssueID4 477–96 Occurrence Handle15178197 Occurrence Handle1:CAS:528:DC%2BD2cXks1eksb4%3D Occurrence Handle10.1016/j.jtbi.2004.02.021

    Article  PubMed  CAS  Google Scholar 

  28. A Fedier RA Steiner VA Schwarz et al. (2003) ArticleTitleThe effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells Int J Oncol 22 IssueID5 1169–73 Occurrence Handle12684687 Occurrence Handle1:CAS:528:DC%2BD3sXjsVOks7Y%3D

    PubMed  CAS  Google Scholar 

  29. JE Quinn RD Kennedy PB Mullan et al. (2003) ArticleTitleBRCA1 functions as a differential modulator of chemotherapy-induced apoptosis Cancer Res 63 IssueID19 6221–8 Occurrence Handle14559807 Occurrence Handle1:CAS:528:DC%2BD3sXotV2jur0%3D

    PubMed  CAS  Google Scholar 

  30. M Thangaraju SH Kaufmann FJ Couch (2000) ArticleTitleBRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines J Biol Chem 275 IssueID43 33487–96 Occurrence Handle10938285 Occurrence Handle1:CAS:528:DC%2BD3cXnvVyjsrs%3D Occurrence Handle10.1074/jbc.M005824200

    Article  PubMed  CAS  Google Scholar 

  31. C Zhou JL Smith J Liu (2003) ArticleTitleRole of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1 Oncogene 22 IssueID16 2396–404 Occurrence Handle12717416 Occurrence Handle1:CAS:528:DC%2BD3sXjt1als7c%3D Occurrence Handle10.1038/sj.onc.1206319

    Article  PubMed  CAS  Google Scholar 

  32. P Tassone P Tagliaferri A Perricelli et al. (2003) ArticleTitleBRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells Br J Cancer 88 IssueID8 1285–91 Occurrence Handle12698198 Occurrence Handle1:CAS:528:DC%2BD3sXivFShsr0%3D Occurrence Handle10.1038/sj.bjc.6600859

    Article  PubMed  CAS  Google Scholar 

  33. Samouelian V, Maugard CM, Jolicoeur M et al. Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A. Cancer Chemother Pharmacol 2004

  34. A Husain G He ES Venkatraman DR Spriggs (1998) ArticleTitleBRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II) Cancer Res 58 IssueID6 1120–3 Occurrence Handle9515792 Occurrence Handle1:CAS:528:DyaK1cXhvV2ku7Y%3D

    PubMed  CAS  Google Scholar 

  35. A Bhattacharyya US Ear BH Koller et al. (2000) ArticleTitleThe breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross- linking agent cisplatin J Biol Chem 275 IssueID31 23899–903 Occurrence Handle10843985 Occurrence Handle1:CAS:528:DC%2BD3cXls12lsrk%3D Occurrence Handle10.1074/jbc.C000276200

    Article  PubMed  CAS  Google Scholar 

  36. DW Abbott ML Freeman JT Holt (1998) ArticleTitleDouble-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells J Natl Cancer Inst 90 IssueID13 978–85 Occurrence Handle9665145 Occurrence Handle1:CAS:528:DyaK1cXksVSnsbg%3D Occurrence Handle10.1093/jnci/90.13.978

    Article  PubMed  CAS  Google Scholar 

  37. ME Moynahan TY Cui M Jasin (2001) ArticleTitleHomology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation Cancer Res 61 IssueID12 4842–50 Occurrence Handle11406561 Occurrence Handle1:CAS:528:DC%2BD3MXks1Grurc%3D

    PubMed  CAS  Google Scholar 

  38. KJ Patel VP Yu H Lee et al. (1998) ArticleTitleInvolvement of Brca2 in DNA repair Mol Cell 1 IssueID3 347–57 Occurrence Handle9660919 Occurrence Handle1:CAS:528:DyaK1cXhtlyhtbs%3D Occurrence Handle10.1016/S1097-2765(00)80035-0

    Article  PubMed  CAS  Google Scholar 

  39. R Scully DM Livingston (2000) ArticleTitleIn search of the tumour-suppressor functions of BRCA1 and BRCA2 Nature 408 IssueID6811 429–32 Occurrence Handle11100717 Occurrence Handle1:CAS:528:DC%2BD3cXos1Srsbw%3D Occurrence Handle10.1038/35044000

    Article  PubMed  CAS  Google Scholar 

  40. X Xu W Qiao SP Linke et al. (2001) ArticleTitleGenetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis Nat Genet 28 IssueID3 266–71 Occurrence Handle11431698 Occurrence Handle1:CAS:528:DC%2BD3MXltFSmtL8%3D Occurrence Handle10.1038/90108

    Article  PubMed  CAS  Google Scholar 

  41. D Cortez Y Wang J Qin SJ Elledge (1999) ArticleTitleRequirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks Science 286 IssueID5442 1162–6 Occurrence Handle10550055 Occurrence Handle1:CAS:528:DyaK1MXnt1Krsb4%3D Occurrence Handle10.1126/science.286.5442.1162

    Article  PubMed  CAS  Google Scholar 

  42. KK Khanna SP Jackson (2001) ArticleTitleDNA double-strand breaks: Signaling, repair and the cancer connection Nat Genet 27 IssueID3 247–54 Occurrence Handle11242102 Occurrence Handle1:CAS:528:DC%2BD3MXhslKqtLg%3D Occurrence Handle10.1038/85798

    Article  PubMed  CAS  Google Scholar 

  43. SSF Yuan SY Lee G Chen et al. (1999) ArticleTitleBRCA2 is required for ionizing radiation-induced assembly of rad51 complex in vivo Cancer Res 59 IssueID15 3547–51 Occurrence Handle10446958 Occurrence Handle1:CAS:528:DyaK1MXltFCgtbo%3D

    PubMed  CAS  Google Scholar 

  44. P Freneaux D Stoppa-Lyonnet E Mouret et al. (2000) ArticleTitleLow expression of bcl-2 in Brca1-associated breast cancers Br J Cancer 83 IssueID10 1318–22 Occurrence Handle11044356 Occurrence Handle1:CAS:528:DC%2BD3cXos12hu7g%3D Occurrence Handle10.1054/bjoc.2000.1438

    Article  PubMed  CAS  Google Scholar 

  45. PC Hanawalt (2001) ArticleTitleRevisiting the rodent repairadox Environ Mol Mutagen 38 IssueID2–3 89–96 Occurrence Handle11746740 Occurrence Handle1:CAS:528:DC%2BD3MXotlansLc%3D Occurrence Handle10.1002/em.1057

    Article  PubMed  CAS  Google Scholar 

  46. C Egawa K Motomura Y Miyoshi et al. (2003) ArticleTitleIncreased expression of BRCA1 mRNA predicts favorable response to anthracycline-containing chemotherapy in breast cancers Breast Cancer Res Treat 78 IssueID1 45–50 Occurrence Handle12611456 Occurrence Handle1:CAS:528:DC%2BD3sXntV2rtw%3D%3D Occurrence Handle10.1023/A:1022101310500

    Article  PubMed  CAS  Google Scholar 

  47. A Catteau WH Harris CF Xu E Solomon (1999) ArticleTitleMethylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics Oncogene 18 IssueID11 1957–65 Occurrence Handle10208417 Occurrence Handle1:CAS:528:DyaK1MXisVWmtb4%3D Occurrence Handle10.1038/sj.onc.1202509

    Article  PubMed  CAS  Google Scholar 

  48. M Esteller JM Silva G Dominguez et al. (2000) ArticleTitlePromoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors J Natl Cancer Inst 92 IssueID7 564–9 Occurrence Handle10749912 Occurrence Handle1:CAS:528:DC%2BD3cXivFWqtr8%3D Occurrence Handle10.1093/jnci/92.7.564

    Article  PubMed  CAS  Google Scholar 

  49. M Esteller J Garcia-Foncillas E Andion et al. (2000) ArticleTitleInactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents N Engl J Med 343 IssueID19 1350–4 Occurrence Handle11070098 Occurrence Handle1:CAS:528:DC%2BD3cXosFOltLg%3D Occurrence Handle10.1056/NEJM200011093431901

    Article  PubMed  CAS  Google Scholar 

  50. S Geisler PE Lonning T Aas et al. (2001) ArticleTitleInfluence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer Cancer Res 61 IssueID6 2505–12 Occurrence Handle11289122 Occurrence Handle1:CAS:528:DC%2BD3MXisVSksr8%3D

    PubMed  CAS  Google Scholar 

  51. S Geisler AL Borresen-Dale H Johnsen et al. (2003) ArticleTitleTP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer Clin Cancer Res 9 IssueID15 5582–8 Occurrence Handle14654539 Occurrence Handle1:CAS:528:DC%2BD3sXpsVejtbs%3D

    PubMed  CAS  Google Scholar 

  52. W Henning HW Sturzbecher (2003) ArticleTitleHomologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance Toxicology 193 IssueID1–2 91–109 Occurrence Handle14599770 Occurrence Handle1:CAS:528:DC%2BD3sXos1KhsLc%3D Occurrence Handle10.1016/S0300-483X(03)00291-9

    Article  PubMed  CAS  Google Scholar 

  53. E Levy-Lahad A Lahad S Eisenberg et al. (2001) ArticleTitleA single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers Proc Natl Acad Sci USA 98 IssueID6 3232–6 Occurrence Handle11248061 Occurrence Handle1:CAS:528:DC%2BD3MXit1alsLg%3D Occurrence Handle10.1073/pnas.051624098

    Article  PubMed  CAS  Google Scholar 

  54. WW Wang AB Spurdle P Kolachana et al. (2001) ArticleTitleA single nucleotide polymorphism in the 5′ untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers Cancer Epidemiol Biomarkers Prev 10 IssueID9 955–60 Occurrence Handle11535547 Occurrence Handle1:CAS:528:DC%2BD3MXnt1Gis7g%3D

    PubMed  CAS  Google Scholar 

  55. L Kadouri Z Kote-Jarai A Hubert et al. (2004) ArticleTitleA single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers Br J Cancer 90 IssueID10 2002–5 Occurrence Handle15138485 Occurrence Handle1:CAS:528:DC%2BD2cXjvVals7s%3D Occurrence Handle10.1038/sj.bjc.6601837

    Article  PubMed  CAS  Google Scholar 

  56. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 2005 Apr 14; 434(9035): 913–7

  57. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005 Apr 14; 434(7035): 917–21

  58. PO Chappuis J Goffin N Wong et al. (2002) ArticleTitleA significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer J Med Genet 39 IssueID8 608–10 Occurrence Handle12161606 Occurrence Handle1:STN:280:DC%2BD38vgvVKrug%3D%3D Occurrence Handle10.1136/jmg.39.8.608

    Article  PubMed  CAS  Google Scholar 

  59. E Warner M Trudeau C Holloway (2003) ArticleTitleSensitivity of BRCA-1- related breast cancer to neoadjuvant chemotherapy: Practical implications Breast J 9 IssueID6 507–8 Occurrence Handle14616950 Occurrence Handle10.1046/j.1524-4741.2003.09624.x

    Article  PubMed  Google Scholar 

  60. ME Robson PO Chappuis J Satagopan et al. (2004) ArticleTitleA combined analysis of outcome following breast cancer: Differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Res 6 IssueID1 R8–R17 Occurrence Handle14680495 Occurrence Handle1:CAS:528:DC%2BD2cXnsl2hsw%3D%3D Occurrence Handle10.1186/bcr658

    Article  PubMed  CAS  Google Scholar 

  61. J Boyd Y Sonoda MG Federici et al. (2000) ArticleTitleClinicopathologic features of BRCA-linked and sporadic ovarian cancer JAMA 283 IssueID17 2260–5 Occurrence Handle10807385 Occurrence Handle1:CAS:528:DC%2BD3cXjsFaksbY%3D Occurrence Handle10.1001/jama.283.17.2260

    Article  PubMed  CAS  Google Scholar 

  62. SJ Ramus A Fishman PD Pharoah et al. (2001) ArticleTitleOvarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations Eur J Surg Oncol 27 IssueID3 278–81 Occurrence Handle11373105 Occurrence Handle1:STN:280:DC%2BD3M3ptVWmuw%3D%3D Occurrence Handle10.1053/ejso.2000.1097

    Article  PubMed  CAS  Google Scholar 

  63. Y Ben David A Chetrit G Hirsh-Yechezkel et al. (2002) ArticleTitleEffect of BRCA mutations on the length of survival in epithelial ovarian tumors J Clin Oncol 20 IssueID2 463–6 Occurrence Handle11786575 Occurrence Handle1:CAS:528:DC%2BD38XovVKiug%3D%3D Occurrence Handle10.1200/JCO.20.2.463

    Article  PubMed  CAS  Google Scholar 

  64. I Cass RL Baldwin T Varkey et al. (2003) ArticleTitleImproved survival in women with BRCA-associated ovarian carcinoma Cancer 97 IssueID9 2187–95 Occurrence Handle12712470 Occurrence Handle1:CAS:528:DC%2BD3sXjvVSjs70%3D Occurrence Handle10.1002/cncr.11310

    Article  PubMed  CAS  Google Scholar 

  65. AC Wolff NE Davidson (2002) ArticleTitlePreoperative therapy in breast cancer: Lessons from the treatment of locally advanced disease Oncologist 7 IssueID3 239–45 Occurrence Handle12065797 Occurrence Handle10.1634/theoncologist.7-3-239

    Article  PubMed  Google Scholar 

  66. Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P, Morandi P, Fan C, Rabiul I, Ross JS, Hortobagyi GN Pusztai L. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res. 2005 Aug 15; 11(16): 5678–85

  67. TA Buchholz et al. (2005) ArticleTitleThe nuclear transcription factor kappaB/bc1-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer Clin Cancer Res. 11 IssueID23 8398–8402 Occurrence Handle16322301 Occurrence Handle1:CAS:528:DC%2BD2MXht1KjsrnF Occurrence Handle10.1158/1078-0432.CCR-05-0885

    Article  PubMed  CAS  Google Scholar 

  68. JV Moyano et al. (2006) ArticleTitleAlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer J Clin Invest. 116 IssueID1 261–270 Occurrence Handle16395408 Occurrence Handle1:CAS:528:DC%2BD28XjslOgtA%3D%3D Occurrence Handle10.1172/JCI25888

    Article  PubMed  CAS  Google Scholar 

  69. HY Chang et al. (2005) ArticleTitleRobustness, Scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Proc Natl Acad Sci U.S.A. 102 IssueID10 3738–3743 Occurrence Handle15701700 Occurrence Handle1:CAS:528:DC%2BD2MXisVOgtr4%3D Occurrence Handle10.1073/pnas.0409462102

    Article  PubMed  CAS  Google Scholar 

  70. SM Rodriguez-Pinilla et al. (2006) ArticleTitlePrognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas Clin Cancer Res. 12 IssueID5 1533–1539 Occurrence Handle16533778 Occurrence Handle1:CAS:528:DC%2BD28XitVGms7g%3D Occurrence Handle10.1158/1078-0432.CCR-05-2281

    Article  PubMed  CAS  Google Scholar 

  71. Banerjee S et al (2006) Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J clin Pathol

  72. PD Pharoah DF Easton DL Stockton et al. (1999) ArticleTitleSurvival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group Cancer Res 59 IssueID4 868–71 Occurrence Handle10029077 Occurrence Handle1:STN:280:DyaK1M7ltFGgtw%3D%3D

    PubMed  CAS  Google Scholar 

  73. RP Zweemer RH Verheijen JW Coebergh et al. (2001) ArticleTitleSurvival analysis in familial ovarian cancer, a case control study Eur J Obstet Gynecol Reprod Biol 98 IssueID2 219–23 Occurrence Handle11574135 Occurrence Handle1:STN:280:DC%2BD3MrivVWruw%3D%3D Occurrence Handle10.1016/S0301-2115(01)00318-9

    Article  PubMed  CAS  Google Scholar 

  74. A Wojciechowska-Lacka J Markowska E Skasko et al. (2003) ArticleTitleFrequent disease progression and early recurrence in patients with familial ovarian cancer primarily treated with paclitaxel and cis- or carboplatin (preliminary report) Eur J Gynaecol Oncol 24 IssueID1 21–4 Occurrence Handle12691311 Occurrence Handle1:STN:280:DC%2BD3s7nt1Khuw%3D%3D

    PubMed  CAS  Google Scholar 

  75. MD Tischkowitz SV Hodgson (2003) ArticleTitleFanconi anaemia J Med Genet 40 IssueID1 1–10 Occurrence Handle12525534 Occurrence Handle1:CAS:528:DC%2BD3sXht1ymsb0%3D Occurrence Handle10.1136/jmg.40.1.1

    Article  PubMed  CAS  Google Scholar 

  76. NG Howlett T Taniguchi S Olson et al. (2002) ArticleTitleBiallelic inactivation of BRCA2 in Fanconi anemia Science 297 IssueID5581 606–9 Occurrence Handle12065746 Occurrence Handle1:CAS:528:DC%2BD38XlslWrs7k%3D Occurrence Handle10.1126/science.1073834

    Article  PubMed  CAS  Google Scholar 

  77. AR Venkitaraman (2004) ArticleTitleTracing the network connecting BRCA and Fanconi anaemia proteins Nat Rev Cancer 4 IssueID4 266–76 Occurrence Handle15057286 Occurrence Handle1:CAS:528:DC%2BD2cXis1Gmt7s%3D Occurrence Handle10.1038/nrc1321

    Article  PubMed  CAS  Google Scholar 

  78. T Taniguchi M Tischkowitz N Ameziane et al. (2003) ArticleTitleDisruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors Nat Med 9 IssueID5 568–74 Occurrence Handle12692539 Occurrence Handle1:CAS:528:DC%2BD3sXjtlamtLo%3D Occurrence Handle10.1038/nm852

    Article  PubMed  CAS  Google Scholar 

  79. JL Hilton JP Geisler JA Rathe et al. (2002) ArticleTitleInactivation of BRCA1 and BRCA2 in ovarian cancer J Natl Cancer Inst 94 IssueID18 1396–406 Occurrence Handle12237285 Occurrence Handle1:CAS:528:DC%2BD38Xnt1Gnurc%3D

    PubMed  CAS  Google Scholar 

  80. ME Robson J Boyd PI Borgen HS Cody SuffixIII (2001) ArticleTitleHereditary breast cancer Curr Probl Surg 38 IssueID6 387–480 Occurrence Handle11375625 Occurrence Handle1:STN:280:DC%2BD3M3pt1Crsw%3D%3D Occurrence Handle10.1016/S0011-3840(01)70035-4

    Article  PubMed  CAS  Google Scholar 

  81. WD Foulkes J Rosenblatt PO Chappuis (2001) ArticleTitleThe contribution of inherited factors to the clinicopathological features and behavior of breast cancer J Mammary Gland Biol Neoplasia 6 IssueID4 453–65 Occurrence Handle12013534 Occurrence Handle1:STN:280:DC%2BD383ntVGlsQ%3D%3D Occurrence Handle10.1023/A:1014791115760

    Article  PubMed  CAS  Google Scholar 

  82. Lakhani SR, Gusterson BA, Jacquemier J et al. The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 2000; 6(3): 782–9

    Google Scholar 

  83. CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 2004; 74(6): 1175–82

    Google Scholar 

  84. MD Schwartz C Lerman B Brogan et al. (2004) ArticleTitleImpact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients J Clin Oncol 22 IssueID10 1823–9 Occurrence Handle15067026 Occurrence Handle10.1200/JCO.2004.04.086

    Article  PubMed  Google Scholar 

  85. B Weigelt Z Hu X He C Livasy LA Carey MG Ewend AM Glas CM Perou LJ Van’t Veer (2005) ArticleTitleMolecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer Cancer Res. 65 IssueID20 9155–8 Occurrence Handle16230372 Occurrence Handle1:CAS:528:DC%2BD2MXhtFWmu77N Occurrence Handle10.1158/0008-5472.CAN-05-2553

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada, H2W 1S6

    William D. Foulkes

Authors
  1. William D. Foulkes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William D. Foulkes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Foulkes, W.D. BRCA1 and BRCA2: Chemosensitivity, Treatment Outcomes and Prognosis. Familial Cancer 5, 135–142 (2006). https://doi.org/10.1007/s10689-005-2832-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-005-2832-5

Key words

Search

Navigation